Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...

Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...

The test confirms the scientific validity of the biomarkers used in the lab, led by researcher Carleara Weiss, and increases ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Researchers have discovered a defect in how cells produce exosomes, a problem linked to a mutation found in patients with dementia. They may be incredibly small, but their impact on human health could ...

Three years after Chris Hemsworth shared he had a gene that elevates his likelihood of developing Alzheimer’s, he detailed ...

Share on PinterestNovo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...

Thousands of people have it, and thousands more are impacted by it. We're talking about Alzheimer's disease. But there's hope ...

Administering an amino acid used to treat high blood pressure also appears to reverse signs of dementia in mice.

Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and ...